期刊文献+

绵阳地区献血人群HBV流行率和新发率调查分析

Investigation on the HBV prevalence status among blood donors in Mianyang
下载PDF
导出
摘要 目的计算和分析绵阳地区献血人群2008年1月-2010年12月HBV的流行率、新发率,评估HBV在绵阳地区的献血人群中的流行情况。方法收集2008年1月-2010年12月100 429人次献血者人口统计学资料、ELISA试剂初筛和确证实验数据。计算初次献血者和重复献血者的HBV流行率,进一步评估重复献血人群中HBV的新发率。结果 2008年1月-2010年12月绵阳地区初次献血和重复献血人群的HBV流行率依次为0.97%和0.04%,重复献血人群中的HBV感染新发率为0.32%。结论绵阳地区献血人群具有较高的流行率和新发率,可能引起较高的HBV输血残余风险,应考虑采用第4代ELISA初筛试剂和核酸检测(NAT)降低该地区的HBV对血液安全的影响。 Objective To analyze the prevalence、incidence rate of HBV among blood donors in Mianyang from January2008 to December 2010. Methods The demographic information、parallel screening with the third generation ELISA kits and confirmatory testing results were collected from 100429 donations. The prevalence rates on first and repeat donors were calculated,as well as the incidence rates using the reported incidence evaluation model. Results During the study period,the prevalence rates among first and repeat donors were 0. 97% and 0. 04% respectively and the HBV incidence rate on repeat donors was 0. 32%. Conclusion Relative high HBV prevalence and incidence rates in Mianyang may lead to high HBV transfusion residual risk,and the fourth generation ELISA screening assays and NAT testing were suggested to be implemented reducing the impact of HBV on blood safety in Mianyang.
出处 《中国输血杂志》 CAS 北大核心 2016年第7期730-732,共3页 Chinese Journal of Blood Transfusion
关键词 绵阳地区 献血人群 HBV 流行率 新发率 Mianyang Blood donors HBV Prevalence rate incidence rate
  • 相关文献

参考文献17

  • 1Custer B,Sullivan SD,Hazlet TK,et al.Global epidemiology of hepatitis B virus.J Clin Gastroenterol 2004,38(2):158-168.
  • 2Candotti D,Allain JP.Transfusion-transmitted hepatitis B virus infection.J Hepatol 2009,51(4):798-809.
  • 3Liang X,Bi S,Yang W,et al.Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination.Vaccine,2009,27(12):6550-6557.
  • 4Kleinman SH,Busch MP.Assessing the impact of HBV NAT on window period reduction and residual risk.J Clin Virol,2006,36(Suppl 1):S23-s29.
  • 5Biswas R,Tabor E,Hsia CC,et al.Comparative sensitivity of HBV NATs and HBs Ag assays for detection of acute HBV infection.Transfusion,2003,43(3):788-798.
  • 6Schreiber GB,Busch MP,Kleinman SH,et al.The risk of transfusion-transmitted viral infections.The Retrovirus Epidemiology Donor Study.N Engl J Med,1996,334(7):1685-1690.
  • 7Korelitz JJ,Busch MP,Kleinman SH,et al.A method for estimating hepatitis B virus incidence rates in volunteer blood donors.National Heart,Lung,and Blood Institute Retrovirus Epidemiology Donor Study.Transfusion,1997,37(5):634-640.
  • 8Lavanchy D.Hepatitis B virus epidemiology,disease burden,treatment,and current and emerging prevention and control measures.J Viral Hepat,2004,11(7):97-107.
  • 9黄珂,戎霞,花文峰,熊华平,许茹,王敏,黄杰庭,廖峭,付涌水.2010~2011年广州地区输血传播HBV、HCV、HIV残余风险评估[J].中国输血杂志,2013,26(2):128-131. 被引量:28
  • 10Li W,Gao Z,Yang C,et al.The estimation of prevalence,incidence,and residual risk of transfusion-transmitted human hepatitis B infection from blood donated at the Anhui blood center,China,from 2009 to 2011.PLo S One,2013,8(3):e73472.

二级参考文献56

  • 1王临旭,黄长形,李新红,王毕娟,尹晨.慢性乙型肝炎病毒感染自然史中表面抗原水平的研究[J].中华临床医师杂志(电子版),2011,5(17):5122-5124. 被引量:7
  • 2吴疆,张卫,韩莉莉,林长缨,林晖,邢玉兰,高培,龚晓红,刘立荣,黄芳,刘健英,刘利英,王化勇,于海柱,刘秀军,唐雅清,蒲永兰,赵伟,王晨,张震,马立宪.北京市人群乙型肝炎血清流行病学研究[J].中华流行病学杂志,2007,28(6):555-557. 被引量:78
  • 3Dodd R,Kurt Roth W,Ashford P,et al.Transfusion medicinandsafety.Biologicals,2009,37(1):62-70.
  • 4Glynn SA,Kleinman SH,Wright DJ,et al.International applicationof the incidence rate/window period model.Transfusion,2002,42(8):966-972.
  • 5Correll PK,Law MG,Seed CR,et al.Variant Creutzfeldt-Jakob dis-ease in Australian blood donors:estimation of risk and the impactof deferral strategies.Vox Sang,2001,81(1):6-11.
  • 6Dodd RY,Notari EPt,Stramer SL.Current prevalence and inci-dence of infectious disease markers and estimated window-periodrisk in the American Red Cross blood donor population.Transfu-sion,2002,42(8):975-979.
  • 7Gonzalez M,Regine V,Piccinini V,et al.Residual risk of transfusion-transmitted human immunodeficiency virus,hepatitis C virus,and hep-atitis B virus infections in Italy.Transfusion,2005,45(10):1670-1675.
  • 8Velati C,Romano L,Baruffi L,et al.Residual risk of transfusion-transmitted HCV and HIV infections by antibody-screened blood inItaly.Transfusion,2002,42(8):989-993.
  • 9Al Shaer L,Abdulrahman M,John TJ and Alhashimi A.Trends inprevalence,incidence,and residual risk of major transfusion-trans-missible viral infections in United Arab Emirates blood donors:im-pact of individual-donation nucleic acid testing,2004 through2009.Transfusion,2012,52(11):2300-2309.
  • 10Barreto CC,Sabino EC,Goncalez TT,et al.Prevalence,incidence,and residual risk of human immunodeficiency virus among commu-nity and replacement first-time blood donors in Sao Paulo,Brazil.Transfusion,2005,45(11):1709-1714.

共引文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部